Duloxetine versus other anti-depressive agents for depression
Worth asking your prescriber what duloxetine offers in your specific situation over alternatives that were easier to stay on in these trials, such as escitalopram.
Well-supported by good-quality research. how we score evidence
Caveat on this rating: All included studies were industry funded, and only four were not sponsored by duloxetine's manufacturer; the review authors cautioned that sponsorship bias may overestimate treatment effects.
Across 16 randomised trials with 5,735 participants, duloxetine was no more effective for depression than other antidepressants (for example, odds ratio 1.31, 95% CI 0.87 to 1.97 versus escitalopram), and more people stopped taking it than stopped escitalopram (odds ratio 1.62, 95% CI 1.01 to 2.62) or venlafaxine (odds ratio 1.56, 95% CI 1.14 to 2.15).
Worth asking
Worth asking your prescriber what duloxetine offers in your specific situation over alternatives that were easier to stay on in these trials, such as escitalopram.
What it is FDA approved for
Read off the label. Trial duration and approval year are shown only where they were recorded — never inferred.
- Major depressive disorder (adults)
- Generalized anxiety disorder (adults and pediatric patients 7 years and older)
- Diabetic peripheral neuropathic pain (adults)
- Fibromyalgia (adults and pediatric patients 13 years and older)
- Chronic musculoskeletal pain (adults)
Source
Duloxetine versus other anti-depressive agents for depression — Cipriani A, et al. (2012)
Top-tier peer-reviewed journal
Read the source: https://doi.org/10.1002/14651858.CD006533.pub2
DOI: 10.1002/14651858.CD006533.pub2
How this was scored
- Study design
- Meta-analysis of randomised trials
- Funding
- Funding not disclosed
- Published in
- Top-tier peer-reviewed journal
- Sample size
- 5,735
- Preregistered
- Yes
- Conflicts disclosed
- No
- Independent of proponent
- not recorded
- Retracted
- No
Read the full scoring rubric, including what it can't tell you.
Published August 19, 2026.
Questions
How strong is the evidence behind this?
Resolv rates this source "strong evidence". Well-supported by good-quality research. It scores 77 out of 100 on our published rubric. One caveat travels with that badge: All included studies were industry funded, and only four were not sponsored by duloxetine's manufacturer; the review authors cautioned that sponsorship bias may overestimate treatment effects. The score is calculated from recorded facts about the source — study design, funding, publication venue, sample size, preregistration — not typed in by an editor.
What is the source for this?
Duloxetine versus other anti-depressive agents for depression — Cipriani A, et al. (2012). Published in: Top-tier peer-reviewed journal. DOI: 10.1002/14651858.CD006533.pub2. The full source is linked on this page so you can read it yourself.
Who paid for this research, and does that matter?
Study design: Meta-analysis of randomised trials. Funding: Funding not disclosed. Independence from the proponent is not recorded. Industry sponsorship is one of the most reliably measured biases in medicine, which is why funding carries real weight in the score rather than sitting in a footnote.
Is duloxetine (Cymbalta), cymbalta FDA approved?
Yes — FDA approved for Major depressive disorder (adults), Generalized anxiety disorder (adults and pediatric patients 7 years and older), Diabetic peripheral neuropathic pain (adults), Fibromyalgia (adults and pediatric patients 13 years and older), Chronic musculoskeletal pain (adults). Approval is for a specific indication, not for everything the drug is prescribed for.
Is this medical advice?
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.